gadolinium has been researched along with sorafenib in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flaherty, KT; Heitjan, DF; Kang, HC; Keefe, SM; O'Dwyer, PJ; Rosen, MA; Siegelman, ES; Tan, KS | 1 |
Chen, X; Liu, C; Lu, Y; Miao, H; Tang, B; Wang, L; Xu, Q; Yang, Z | 1 |
Jiang, D; Liu, Y; Wang, T; Xiao, Y; Yang, S; Yu, D; Zhang, B; Zhang, J; Zhang, N | 1 |
1 trial(s) available for gadolinium and sorafenib
Article | Year |
---|---|
MRI assessment of early tumor response in metastatic renal cell carcinoma patients treated with sorafenib.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Contrast Media; Female; Gadolinium; Humans; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib | 2013 |
2 other study(ies) available for gadolinium and sorafenib
Article | Year |
---|---|
Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats.
Topics: Angiogenic Proteins; Animals; Anti-Inflammatory Agents; Cytokines; Dimethylnitrosamine; Drug Therapy, Combination; Gadolinium; Hepatic Stellate Cells; Hepatocytes; Hydroxyproline; Kupffer Cells; Liver; Liver Cirrhosis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Rats; Rats, Wistar; Sorafenib | 2015 |
Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Contrast Media; Drug Delivery Systems; Drug Liberation; Female; Gadolinium; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Mice; Microscopy, Electron, Transmission; Niacinamide; Phenylurea Compounds; Sorafenib; Tissue Distribution; Treatment Outcome; Tumor Burden | 2016 |